Viewing Study NCT02969369


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-01-05 @ 10:35 PM
Study NCT ID: NCT02969369
Status: COMPLETED
Last Update Posted: 2024-07-05
First Post: 2016-11-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-12-31
Start Date Type: ACTUAL
Primary Completion Date: 2020-04-20
Primary Completion Date Type: ACTUAL
Completion Date: 2020-04-20
Completion Date Type: ACTUAL
First Submit Date: 2016-11-17
First Submit QC Date: None
Study First Post Date: 2016-11-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2023-04-10
Results First Submit QC Date: None
Results First Post Date: 2023-06-05
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2021-04-14
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-06-25
Last Update Post Date: 2024-07-05
Last Update Post Date Type: ACTUAL